Inhibiting angiogenesis by oral immunisation with poly(ε-caprolactone) -poly(ethylene glycol)-poly(ε-caprolactone) nanoparticle-encapsulated basic fibroblast growth factor

Micro and Nano Letters

Volumn 6, Issue 4, 2011, Pages 221-225

  Long, Jianlin ^a   Liu, Wei ^b   Li, Lin ^b   Wang, Pan ^b   Gou, Maling ^a   Huang, Meijuan ^a   Guo, Gang ^a   Men, Ke ^a   Qian, Zhiyong ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BASIC FIBROBLAST GROWTH FACTOR; CANCER IMMUNOTHERAPY; CAPROLACTONE; IN-VITRO; IN-VIVO; MEAN DIAMETER; MONODISPERSE; NOVEL STRATEGIES; TUMOUR CELLS;

CELL CULTURE; ETHYLENE; ETHYLENE GLYCOL; FIBROBLASTS; IMMUNIZATION; NANOPARTICLES; PEPTIDES; POLYETHYLENE OXIDES;

POLYETHYLENE GLYCOLS;

AUTOANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; MACROGOL; NANOPARTICLE; POLYCAPROLACTONE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIBODY TITER; ARTICLE; CANCER INHIBITION; CHEMICAL BOND; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; HYDROLYSIS; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN;

EID: 79957447615     PISSN: None     EISSN: 17500443     Source Type: Journal    
DOI: 10.1049/mnl.2011.0059     Document Type: Article

References (37)

1. Folkman, J.: ' Angiogenesis ', Annu. Rev. Med., 2006, 57, p. 1-18 10.1146/annurev.med.57.121304.131306 (Pubitemid 43261975)
2. Hagedorn, M., and Bikfalvi, A.: ' Target molecules for anti-angiogenic therapy: from basic research to clinical trials ', Crit. Rev. Oncol. Hematol., 2000, 34, p. 89-110 10.1016/S1040-8428(00)00056-1 (Pubitemid 30229919)
3. Wang, L.L., Li, J.J., Zheng, J.B., Liu, H.Y., Du, G.J., and Li, S.: ' Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells ', Eur. J. Pharmacol., 2004, 502, p. 1-10 10.1016/j.ejphar.2004.07.048 (Pubitemid 39328076)
4. Plum, S.M., Holaday, J.W., Ruiz, A., Madsen, J.W., Fogler, W.E., and Fortier, A.H.: ' Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development ', Vaccine, 2000, 19, p. 1294-1303 10.1016/S0264-410X(00)00210-3 (Pubitemid 32008298)
5. Hori, A., Sasada, R., and Matsutani, E.: et al. ' Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor ', Cancer Res., 1991, 51, p. 6180-6184
6. Boon, T., Coulie, P.G., and van den Eynde, B.: ' Tumor antigens recognized by T cells ', Immunol. Today, 1997, 18, p. 267-268 10.1016/S0167-5699(97)80020-5 (Pubitemid 27261443)
7. Rosenberg, S.A.: ' Cancer vaccines based on the identification of genes encoding cancer regression antigens ', Immunol. Today, 1997, 18, p. 175-178 10.1016/S0167-5699(97)84664-6 (Pubitemid 27192179)
8. Gouttefangeas, C., and Rammensee, H.G.: ' Problem solving for tumor immunotherapy ', Nat. Biotechnol., 2000, 18, p. 491-492 10.1038/75343 (Pubitemid 30313950)
9. Grossman, Z., and Paul, W.E.: ' Self-tolerance: context dependent tuning of T cell antigen recognition ', Semin. Immunol., 2000, 12, p. 197-203 10.1006/smim.2000.0232 (Pubitemid 30479439)
10. Kang, L., Tomonori, I., Marzena, S., Yukino, K., Kayo, I., and Steinman, R.M.: ' Immune tolerance after delivery of dying cells to dendritic cells in Situ ', J. Exp. Med., 2002, 196, p. 1091-1097 10.1084/jem.20021215 (Pubitemid 35231767)
11. Anderton, S.M., Viner, N.J., Matharu, P., Lowrey, P.A., and Wraith, D.C.: ' Influence of a dominant cryptic epitope on autoimmune T cell tolerance ', Nat. Immunol., 2002, 3, p. 175-181 10.1038/ni756 (Pubitemid 34141448)
12. Sigmund, K., and Nowak, M.A.: ' Evolution: tides of tolerance ', Nature, 2001, 414, p. 403-405 10.1038/35106672 0028-0836
13. Shortman, K., and Heath, W.R.: ' Immunity or tolerance? That is the question for dendritic cells ', Nat. Immunol., 2001, 2, p. 988-989 10.1038/ni1101-988 (Pubitemid 33069489)
14. Liu, J.Y., Wei, Y.Q., and Yang, L.: et al. ' Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 ', Blood, 2003, 102, p. 1815-1823 10.1182/blood-2002-12-3772 (Pubitemid 37022578)
15. Wei, Y.Q., Huang, M.J., and Yang, L.: et al. ' Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen ', Proc. Natl. Am. Soc, USA, 2001, 98, p. 11545-11550 10.1073/pnas.191112198 (Pubitemid 32928765)
16. Lu, Y., Wei, Y., and Tian, L.: et al. ' Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor recepto ', J. Immunol., 2003, 170, p. 3162-3170 (Pubitemid 36302193)
17. Magistris, M.T.D.: ' Mucosal delivery of vaccine antigens and its advantages in pediatrics ', Adv. Drug Deliv. Rev., 2006, 58, p. 52-67 10.1016/j.addr.2006.01.002
18. Mastroeni, P., Bowe, F., Cahill, R., Simmons, C., and Dougan, G.: ' Vaccines against gut pathogens ', Gut, 1999, 45, p. 633-635 10.1136/gut.45.5.633 (Pubitemid 29492127)
19. Lee, V.H.L., and Yamamoto, A.: ' Penetration and enzymatic barriers to peptide absorption ', Adv. Drug Deliv. Rev., 1990, 4, p. 171-207 10.1016/0169-409X(89)90018-5
20. Coppi, G., Iannuccelli, V., Sala, N., and Bondi, M.: ' Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administration ', J. Microencapsul., 2004, 21, p. 829-839 10.1080/02652040400015437 (Pubitemid 40109548)
21. van der Lubben, I.M., Konings, F.A., Borchard, G., Verhoef, J.C., and Junginger, H.E.: ' In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry ', J. Drug Target, 2001, 9, p. 39-47 10.3109/ 10611860108995631 (Pubitemid 32496449)
22. Mcclean, S., Prosser, E., and Meehan, E.: et al. ' Binding and uptake of biodegradable poly-di-lactide micro- and nanoparticles in intestinal epithelia ', Eur. J. Pharm. Sci., 1998, 6, p. 153-163 10.1016/S0928-0987(97)10007-0 (Pubitemid 28164286)
23. Uto, T., Wang, X., and Sato, K.: et al. ' Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity ', J. Immunol., 2007, 178, p. 2979-2986 (Pubitemid 46333177)
24. Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., and Bachmann, M.F.: ' Nanoparticles target distinct dendritic cell populations according to their size ', Eur. J. Immunol., 2008, 38, p. 1404-1413 10.1002/eji.200737984
25. Mowat, A.M.: ' Dendritic cells and immune responses to orally administered antigens ', Vaccine, 2005, 23, p. 1797-1799 10.1016/j.vaccine.2004. 11.008 (Pubitemid 40331847)
26. Edlund, U., and Albertsson, A.C.: ' Degradable polymer microspheres for controlled drug delivery ', Adv. Polym. Sci., 2002, 157, p. 67-112 10.1007/3-540-45734-8-3
27. Beck, L.R., Pope, V.Z., Coesar, D.R., Lewis, D.D., and Tice, T.T.: ' Evaluation of a new three-month injectable contraceptive microsphere system in primates ', Contraceptive. Deliv. Syst., 1980, 1, p. 79-84
28. Beck, L., Pope, V.Z., and Flower, C.E.: et al. ' Poly-(di-lactide-co- glycolide)/norhisterone microcapsules: an injectable biodegradable contraceptive ', Biol. Reprod., 1983, 28, p. 186-195 10.1095/biolreprod28.1.186 (Pubitemid 13130541)
29. Pitt, C.G.: ' The controlled parenteral delivery of polypeptide and proteins ', Int. J. Pharmcol., 1990, 59, p. 173-196 10.1016/0378-5173(90)90108-G (Pubitemid 20146149)
30. Gou, M.L., Qian, Z.Y., and Wang, H.: et al. ' Preparation and characterization of magnetic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) microspheres ', J. Mater. Sci.: Mater. Med., 2008, 19, p. 1033-1041 10.1007/s10856-007-3230-3 (Pubitemid 351337488)
31. Zhou, S., Deng, X., and Yang, H.: ' Biodegradable poly(ε- caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system ', Biomaterials, 2003, 24, p. 3563-3570 10.1016/S0142-9612(03)00207-2 0142-9612 (Pubitemid 36703130)
32. Huang, M.J., Gou, M.L., and Qian, Z.Y.: et al. ' One-step preparation of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery ', J. Biomed. Mater. Res. A., 2008, 86A, p. 979-986 10.1002/jbm.a.31704
33. Gou, M.L., Dai, M., and Gu, Y.C.: et al. ' Basic fibroblast growth factor loaded biodegradable PCL-PEG-PCL copolymeric nanoparticles: preparation, in vitro release and immunogenicity study ', J. Nanosci. Nanotechnol., 2008, 8, p. 2357-2361 10.1166/jnn.2008.310 1533-4880 (Pubitemid 351570298)
34. Gou, M.L., Huang, M.J., and Qian, Z.Y.: et al. ' Preparation of anionic poly(ε-caprolactone)-poly(ethyleneglycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier ', Growth Factors, 2007, 25, p. 202-208 10.1080/08977190701671613 (Pubitemid 350214968)
35. Hoffmann, J., Schirner, M., Menrad, A., and Schneider, M.R.: ' A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells ', Cancer Res., 1997, 57, p. 3847-3851 (Pubitemid 27381234)
36. Waldmann, T.A.: ' Immunotherapy: past, present and future ', Nat. Med., 2003, 9, p. 269-277 10.1038/nm0303-269 (Pubitemid 36362781)
37. Gelinas, D.S., Dasilva, K., Fenili, D., St. George-Hyslop, P., and Mclaurin, J.: ' Immunotherapy for Alzheimer's disease ', Proc. Natl. Acad. Sci. USA, 2004, 101, p. 14657-14662 10.1073/pnas.0404866101 0027-8424 (Pubitemid 39346739)